Ameliorating effects of rosemary and costus on blood-associated toxicity in Ehrlich-bearing mice treated with cisplatin | ||||
| Egyptian Journal of Cancer and Biomedical Research | ||||
| Article 7, Volume 5, Issue 4, December 2021, Page 85-98 PDF (1.58 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/jcbr.2021.84374.1219 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Yousry El-Bolkiny ; Mohamed Salem ; Sabry El-Naggar ; Fatma El-Sharkawy 
| ||||
| Department of Zoology, Faculty of Science, Tanta University, Tanta, Egypt. | ||||
| Abstract | ||||
| Background:Rosemary (ROLE) and costus (SLRE) have been established to show antioxidant effects. Aim: This study aimed to evaluate the ameliorating effects of ROLE and SLRE to the side-effects induced by cisplatin (CIS) in tumor-bearing mice. Materials and Methods: Extracts of ROLE and SLRE were examined for their phytochemical activities. To ecaluate their anti-tumor effects, mice were inoculated intraperitoneally (i.p.) with 2.5x105 Ehrlich ascites carcinoma (EAC) and then treated i.p. with CIS at days 3-7 and with ROLE (dose) or SLRE (dose) at days 3-14. Mice were sacrificed on day 14 for CBC and T-cell analyses. Results: Phytochemical analysis revealed that both ROLE and SLRE showed similar antioxidant activities. Treatment of EAC-bearing mice with CIS induced antitumor efficacy of about 90%. Treatment with CIS in combination of ROLE or SLRE did not further enhance the the antitumor activity of CIS. However, co-administration of ROLE or SLRE with CIS increased significantly the antitumor efficacy of CIS. Flow cytometric analysis showed that the numbers of CD4+ and CD8+ T cells were decreased in EAC bearing mice after treatment with CIS. Treatment with both ROLE and SLRE improved the number of these cells. Conclusion: Combinatorial treatment with rosemary and costus | ||||
| Keywords | ||||
| CBC; Cisplatin; Costus; Ehrlich Ascites; Lymphocytes; Rosemary; Tumor | ||||
|
Statistics Article View: 389 PDF Download: 535 |
||||
